Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Hospitalization by Nursing Home and Long-Term Care Units in Ile-de-France Region

NCT ID: NCT06677645

Last Updated: 2025-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

258 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-20

Study Completion Date

2027-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi-center study involving many hospital departments temporary accommodation at the end of hospitalization in several Nursing home/long term care units in Ile de France region. The temporary accommodation program was designed for elderly people living at home to find an accommodation solution in nursing home to meet a short-term need. Temporary accommodation beds are deployed and perpetuated in the Île-de-France region by the Regional Health Agency, physically grouped together in establishments within units with dedicated staff. The resources allocated to these beds have been increased. The aim of the study is to demonstrate the efficiency of the HTSH circuit, for elderly patients leaving hospital, in their medical and social care and the decision or not to return home. This project is supported by Regional Health Agency (ARS-IDF).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Social Care Medical Care Elderly Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prospective group

258 subjects in the prospective group

No interventions assigned to this group

Retrospective group

Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient selection criteria

* Patient male or female at least 60 years of age, as initially defined with the Regional Health Agency, discharged from hospital,
* Oral expression of non opposition to participation in the study, documented in the medical record by the physician,
* Presenting a defined and feasible plan for returning home,
* Whose social/medical situation (stabilized) does not allow an immediate return home after hospitalization.
2. Caregiver selection criteria

* Person with an unpaid caregiving activity for their relative in HTSH,
* Person verbally expressing their non-opposition to participating in the study, and documented in the medical record of the patient they are helping,
* A person who is able to understand the study questionnaires and evaluations, and is able to answer them without the help of a third party.
3. Professional selection criteria

* Salaried professional, nursing or not, regularly and directly involved in the HTSH circuit, whether in hospital or in nursing home / long term care units, for at least 6 months,
* Oral expression of non opposition to participation in the study, documented by the establishment.

* Be already included in another clinical study,
* Benefit from a legal protection measure or be unable to express their consent, in accordance with article L1121-8 of the French Public Health Code.
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gérond'if

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Résidence ZEMGOR

Cormeilles-en-Parisis, , France

Site Status NOT_YET_RECRUITING

EHPAD Pierre TABANOU

L'Haÿ-les-Roses, , France

Site Status RECRUITING

Groupe Hospitalier Sud Ile de France (GHSIF)

Melun, , France

Site Status NOT_YET_RECRUITING

GHU Lariboisière

Paris, , France

Site Status NOT_YET_RECRUITING

Broca Hospital

Paris, , France

Site Status RECRUITING

USDL Vaugirard, APHP

Paris, , France

Site Status RECRUITING

Centre Hospitalier de Rambouillet

Rambouillet, , France

Site Status NOT_YET_RECRUITING

Centre Hospitalier de Versailles

Versailles, , France

Site Status ACTIVE_NOT_RECRUITING

Hopital Paul Brousse

Villejuif, , France

Site Status NOT_YET_RECRUITING

CHU Bicêtre

Paris, Île-de-France Region, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ISABELLE DUFOUR

Role: CONTACT

33 (0) 185781011

Albatoul ZAKARIA, PhD

Role: CONTACT

33 (0)185 781010

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

François CHARY, Dr

Role: primary

33 (0)1 34 50 43 50

Richard CABROLIER, Dr

Role: primary

33(0)7 86 05 23 53

Cyrus MOINI, Dr

Role: primary

33(0)1 81 74 20 36

Marie JAGER, Dr

Role: primary

+33 0619229316

Olivier HANON, Professor

Role: primary

33 (0) 1 44 08 33 81

Galdric ORVOEN, Dr

Role: primary

33 (0)1 44 08 36 44

Bruno THUBERT, Dr

Role: primary

+33 0670117178

Johane CEDILE, Dr

Role: primary

+33 0652058294

Pauline RABIER-LEBRUN, Dr

Role: primary

33(0) 1 45 21 70 22

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A00023-44

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study Human Digital Support Transitional Care
NCT06354166 NOT_YET_RECRUITING NA